The global Cardiac Biomarkers Market was valued at USD 20.8 billion in 2025 and is projected to grow from USD 23.0 billion in 2026 to USD 49.3 billion by 2033, registering a CAGR of 11.5% from 2026 to 2033. North America dominated the global market with a 43.3% revenue share in 2025, driven by the high prevalence of cardiovascular diseases (CVDs), widespread adoption of advanced...

Healthcare is rapidly evolving from generalized treatment approaches toward highly individualized medical care. At the center of this transformation lies laboratory testing, which provides precise biological data that helps doctors understand each patient’s unique health profile. Instead of relying solely on symptoms or standard treatment protocols, modern medicine increasingly depends on...

According to a newly published market research report by 24LifeSciences, global Triage B-Type Natriuretic Peptide Testing market was valued at USD 786.2 million in 2023 and is projected to reach USD 1.24 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2024–2030. Triage B-Type Natriuretic Peptide Testing is a critical diagnostic...